Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The plasma membrane transporters that clear extracellular serotonin (5-HT) and norepinephrine (NE), serotonin transporters (SERTs) and NE transporters (NETs), have received considerable attention over the past four decades because of their roles in amine neurotransmitter inactivation. In addition, they interact with many centrally active drugs, including multiple classes of antidepressants such as the serotonin-selective reuptake inhibitors, typified by fluoxetine (Prozac), and the more recently developed norepinephrine-selective transporter antagonists, such as reboxetine. The therapeutic utility of these agents supports biogenic amine theories of affective disorders and raises the question as to whether SERT and NET exhibit a functional genetic variation that could influence risk for behavioral disorders. Although evidence exists that a promoter polymorphism in SERT may influence behavioral states, this contention is not without complexity and its mechanism of action remains poorly understood. The identification of coding variants of NETs and SERTs would offer important opportunities to connect genotype to phenotype. However, given the limited frequency of transporter coding variations evident to date in general population surveys or in psychiatric genetic studies, the identification of informative functional variants of transporters will likely require refined phenotypes. In this regard, NET and SERT play critical roles in cardiovascular and gastrointestinal physiology, respectively. This perspective reviews recent human and mouse studies that suggest how peripheral autonomic phenotypes, linked to genetic disruption of NET and SERT function, can aid in the phenotypic segregation needed for advanced theories of biogenic amine dysfunction and pharmacogenetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Self-citationExpression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933 · cited 2×
“The human NET was the first of the biogenic amine transporters to be cloned and characterized (Pacholczyk et al., 1991), apropos given that NETs were the first neurotransmitter transporters to be understood in terms of a contribution to synaptic signaling and drug response.”
BackgroundSelf-citationOverflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., & Eisenhofer, G. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.963 · Cited by 794 · cited 1×
“NETs have long been implicated in the tight control of synaptic NE in the heart (Esler et al., 1990; Eisenhofer et al., 1991).”
BackgroundOrthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594 · cited 4×
“…regulation of these transporters, particularly the antidepressant-sensitive norepinephrine (NE) transporters (NETs) and serotonin (5-HT) transporters (SERTs), I am puzzled that only a single, validated coding polymorphism has been identified that supports a clinical syndrome (Shannon et al., 2000).”
BackgroundInfluentialSelf-citationThe epidemic of orthostatic tachycardia and orthostatic intolerance
Robertson, D. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40480-x · Cited by 293
Walker, E. A., Katon, W. J., Jemelka, R. P., & Roy-Byrne, P. P. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90133-v · Cited by 195 · cited 6×
“In line with this notion, anxiety disorders are commonly observed to be comorbid with IBS (Walker et al., 1992; Addolorato et al., 1998; Woodman et al., 1998) and gastrointestinal side effects can accompany antidepressant treatment.”
BackgroundInfluentialGlatt, C. E., DeYoung, J. A., Delgado, S., Service, S. K., Giacomini, K. M., Edwards, R. H., Risch, N., & Freimer, N. B. (2001) · Nature Genetics · doi:10.1038/86948 · Cited by 154
Br�ss, M., Kunz, J., Lingen, B., & B�nisch, H. (1993) · Human Genetics · doi:10.1007/bf00218272 · Cited by 127
Cited by
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 448
Harshaw, C. (2015) · Psychological Bulletin · doi:10.1037/a0038101 · Cited by 302
“…that the most important causes of disorder necessarily operate at the level of the brain and the neurons, circuits, and synapses therein—often to the exclusion of large portions of the physiological systems of interest (cf. Blakely, 2001; Kleinman & Becker, 1998; Kuo, 1967; Le Magnen, 1971).”
BackgroundPharmacogenetics of Psychotropic Drug Response
Malhotra, A. K., Murphy, G. M., & Kennedy, J. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.780 · Cited by 300
L??tsch, J., Skarke, C., Liefhold, J., & Geisslinger, G. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443140-00003 · Cited by 256
Narboux-Nême, N., Pavone, L. M., Avallone, L., Zhuang, X., & Gaspar, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.020 · Cited by 148
Metadata
- Authors
- Blakely, R. D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-11-01
- Volume
- 21
- Issue
- 21
- Pages
- 8319-8323
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1855620479
- Cited by
- 69
- References
- 9
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind. https://app.cochat.ai/papers/10.1523/jneurosci.21-21-08319.2001
- The paper
- Blakely, R. D. (2001). Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.21-21-08319.2001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.